An analysis of the patient assistance program launched by the big pharmaceutical companies of India
The latest decisions of the “Intellectual Property Appellate Board’s (IPAB)”to revoke the patent protection of Gefitinib, the cancer drug patented by AstraZeneca; Pegasys, hepatiti…
Read more